Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frank Hensel

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Journal of Chromatography. A|January 11, 2011
Chromatographic behavior of IgM:DNA complexesPete Gagnon, Frank Hensel, Soon Lee, et al.
Melanoma Research|June 4, 2013
Early development of PAT-SM6 for the treatment of melanomaFrank Hensel, Miriam Eckstein, Andreas Rosenwald, et al.
Cancer Research|January 6, 2010
Diagnostic and therapeutic potential of a human antibody cloned from a cancer patient that binds to a tumor-specific variant of transcription factor TAF15Nicole Schatz, Stephanie Brändlein, Kilian Rückl, et al.
Oncology Reports|March 10, 2005
Human antibody SC-1 reduces disseminated tumor cells in nude mice with human gastric cancerBertram Illert, Christoph Otto, H Peter Vollmers, et al.
Oncology Reports|January 24, 2014
Ten-year follow-up of a prospective trial for the targeted therapy of gastric cancer with the human monoclonal antibody PAT-SC1Frank Hensel, Wolfgang Timmermann, Burkhard H A von Rahden, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|February 13, 2008
A new tumor-specific variant of GRP78 as target for antibody-based therapyNicole Rauschert, Stephanie Brändlein, Elisabeth Holzinger, et al.
Human Antibodies|February 22, 2005
PAM-1, a natural human IgM antibody as new tool for detection of breast and prostate precursorsStephanie Brändlein, Matthias Eck, Philipp Ströbel, et al.
Cancer Research|May 3, 2003
Cysteine-rich fibroblast growth factor receptor 1, a new marker for precancerous epithelial lesions defined by the human monoclonal antibody PAM-1Stephanie Brändlein, Ines Beyer, Matthias Eck, et al.
Molecular Cancer Therapeutics|January 24, 2007
The human IgM antibody SAM-6 induces tumor-specific apoptosis with oxidized low-density lipoproteinStephanie Brändlein, Nicole Rauschert, Leo Rasche, et al.
Plos One|May 14, 2013
The natural human IgM antibody PAT-SM6 induces apoptosis in primary human multiple myeloma cells by targeting heat shock protein GRP78Leo Rasche, Johannes Duell, Charlotte Morgner, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Journal of Chromatography. A|January 11, 2011
Chromatographic behavior of IgM:DNA complexesPete Gagnon, Frank Hensel, Soon Lee, et al.
Melanoma Research|June 4, 2013
Early development of PAT-SM6 for the treatment of melanomaFrank Hensel, Miriam Eckstein, Andreas Rosenwald, et al.
Cancer Research|January 6, 2010
Diagnostic and therapeutic potential of a human antibody cloned from a cancer patient that binds to a tumor-specific variant of transcription factor TAF15Nicole Schatz, Stephanie Brändlein, Kilian Rückl, et al.
Oncology Reports|March 10, 2005
Human antibody SC-1 reduces disseminated tumor cells in nude mice with human gastric cancerBertram Illert, Christoph Otto, H Peter Vollmers, et al.
Oncology Reports|January 24, 2014
Ten-year follow-up of a prospective trial for the targeted therapy of gastric cancer with the human monoclonal antibody PAT-SC1Frank Hensel, Wolfgang Timmermann, Burkhard H A von Rahden, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|February 13, 2008
A new tumor-specific variant of GRP78 as target for antibody-based therapyNicole Rauschert, Stephanie Brändlein, Elisabeth Holzinger, et al.
Human Antibodies|February 22, 2005
PAM-1, a natural human IgM antibody as new tool for detection of breast and prostate precursorsStephanie Brändlein, Matthias Eck, Philipp Ströbel, et al.
Cancer Research|May 3, 2003
Cysteine-rich fibroblast growth factor receptor 1, a new marker for precancerous epithelial lesions defined by the human monoclonal antibody PAM-1Stephanie Brändlein, Ines Beyer, Matthias Eck, et al.
Molecular Cancer Therapeutics|January 24, 2007
The human IgM antibody SAM-6 induces tumor-specific apoptosis with oxidized low-density lipoproteinStephanie Brändlein, Nicole Rauschert, Leo Rasche, et al.
Plos One|May 14, 2013
The natural human IgM antibody PAT-SM6 induces apoptosis in primary human multiple myeloma cells by targeting heat shock protein GRP78Leo Rasche, Johannes Duell, Charlotte Morgner, et al.
Pageof 2